Igm Biosciences Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Igm Biosciences Inc in the second quarter 2025?
Igm Biosciences Inc recorded a cumulative net loss of $-53 million during 12 months ending in the second quarter 2025, resulting in a negative return on equity (ROE) of -93.35%.

Within the Major Pharmaceutical Preparations industry 215 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 2797, from total ROE ranking in the first quarter 2025 at 3543.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Equity Change	-17.51 %	-99.57 %	-76.3 %	-68.9 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-53	-199	-196	-220	-220
Return On Equity (TTM)	-93.35 %	-317.97 %	-190.68 %	-155.42 %	-119.02 %
IGMS's Total Ranking	# 2797	# 3543	# 2479	# 2272	# 3365
Equity (TTM) in Millions	101	1	48	79	122
Seq. Equity Change	14359.89 %	-98.55 %	-38.98 %	-35.48 %	-24.12 %
Seq. Net Income Change	-	-	-	-	-

Back to IGMS Management Effectiveness >> IGMS's 5 Years Annual ROE >> Compare IGMS ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 216
Sector	# 473
Overall	# 2797

Return On Equity Statistics
High	Average	Low
-3.48 %	-85.1 %	-317.97 %
(Sep 30 2019)		(Mar 31 2025)

IGMS Annual Return On Equity	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021	(Dec 31 2020) 2020
Total Equity in Millions	48	203	287	245	382
Y / Y Equity Change	-76.3 %	-29.25 %	17.29 %	-35.86 %	58.94 %
Net Income in Millions	-196	-246	-221	-165	-81
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-406.45 %	-121.25 %	-76.97 %	-67.44 %	-21.31 %

Back to IGMS Management Effectiveness >> IGMS's 5 Years Annual ROE >> Compare IGMS ROE to its Competitors

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
IGMS's' Return on Equity at Yahoo Finance
IGMS's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for IGMS's Competitors
Subscribers only: Roe for Igm Biosciences Inc 's Suppliers
Subscribers only: Return On Equity for IGMS's Customers

Companies with similar Return On Equity at Jun 30 2025, within Healthcare Sector

ROE

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.